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ABSTRACT
Objectives: to determine the seroprevalence rate of toxoplasmosis, HIV, syphilis and rubella in a popu-
lation of puerperal women. Methods: a prospective, cross-sectional study was performed from Feb-
ruary 2007 to April 2008 at Hospital Geral, Universidade de Caxias do Sul in a population of 1,510 
puerperal women. Women that gave birth to live born or stillborn infants were included in the study; 
maternal and perinatal variables were analyzed. Descriptive statistics and Pearson’s chi-square with 
occasional Fisher’s correction were used for comparisons. Alpha was set in 5%. Results: a total of 148 
cases of congenital infection (9.8%) were identified: 66 cases of syphilis (4.4%), 40 cases of HIV (2.7%), 
27 cases of toxoplasmosis (1.8%) and 15 cases of rubella (1.0%). In ten cases there was co-infection 
(four cases of HIV and syphilis, two cases of HIV and rubella, one case of HIV and toxoplasmosis, two 
cases of rubella and syphilis, and one case of toxoplasmosis and rubella). In a comparison between pu-
erperal women with and without infection there was no statistical significance in relation to incidence 
of abortions, small for gestational age, prematurity, live births and stillbirths, and prenatal care. Need of 
neonatal intensive care unit (NICU), maternal schooling, maternal age higher than 35 years and drug 
use (alcohol, cocaine and crack) had statistical significance. Conclusion: the prevalence rate of infec-
tions was 9.8%. Need of NICU, maternal schooling lower than eight years, maternal age higher than 35 
years and drug use were significantly associated with occurrence of congenital infection.
Keywords: perinatal infections, congenital infections, clinical diagnosis, seroprevalence.
[Braz J Infect Dis 2010;14(1):24-29]©Elsevier Editora Ltda.
INTRODUCTION
The relationship between pregnancy results and 
maternal colonization by a wide range of bacte-
ria, fungi and viral organisms has been studied for 
many years.1
Since the studies by Norman McAlister 
Gregg,2 an ophthalmologist from Sydney who in 
1941 identified the relationship between occur-
rence of rubella in early pregnancy and occur-
rence of congenital cataract in infants born from 
such pregnancy, interest in intrauterine infections 
has increased and considerable attention has been 
given to diagnosis, prevention and management 
of such infections. Despite the emphasis on treat-
ment of perinatal infections seen in several neo-
natal protocols, many newborns still suffer the 
consequences of maternal infections acquired 
during pregnancy. 
Many factors have contributed to the high 
frequency of these infections. In Brazil the main 
factors are: (1) little knowledge and low avail-
ability of diagnostic methods related to such in-
fections in daily medical practice, which makes 
treatment and early and accurate follow-up dif-
ficult; (2) total lack of knowledge of incidence of 
the aforementioned infectious diseases in many 
obstetrical and neonatal populations, except HIV 
and syphilis in some larger cities; (3) limitations 
of diagnostic examinations to be offered by the 
public network. 
Therefore, due to a growing severity observed 
in Obstetrics/Gynecology and Neonatology De-
partments of Hospital Geral, Universidade de 
Caxias do Sul, identification of the prevalence 
rate of these diseases was performed to set guide-
lines relative to early diagnoses and prevention 
with the aim of reducing vertical transmission 
and its consequences for the newborn. 
MATERIAL AND METHODS
A prospective, cross-sectional study was per-
formed at the Obstetrics/Gynecology De-
partment and Neonatal Intensive Care Unit 
of Hospital Geral, Universidade de Caxias do 
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Sul, which exclusively serve patients from the Brazilian Unified 
Health System (SUS). It included 1,510 puerperal women from 
February/2007 to April/2008. The sample was divided into two 
groups: Group I (n = 148; 9.8%), comprised of puerperal women 
whose examinations were positive to congenital infection and 
Group II (n = 1,362; 90.2%), comprised of puerperal women 
with no infection. 
All puerperal women that gave birth to live born or stillborn 
infants and that signed an informed consent form were included 
in the study. 
The following variables were assessed: (1) maternal: age, 
schooling, job, family income, prenatal care, incidence of abor-
tion, route of delivery, drug addiction; (2) perinatal: frequency 
of small for gestational age (SGA), premature, stillborn and live-
born newborns; need of neonatal intensive care (NIC). 
Women admitted to the study were submitted to collection 
of blood sample to identify HIV, syphilis, toxoplasmosis and ru-
bella during stay in maternity ward. The samples were collected 
on filter paper (Whatman 903® dried blood spot) and sent to the 
Laboratory of HIV/AIDS Research for identification of specific 
antibodies. 
The technique of blood sample collection on filter paper was 
used in accordance with the norms established in the collection 
protocol and are in conformity with the Clinical and Laboratory 
Standards Institute (CLSI) collection manual LA4-A4. A suffi-
cient amount of blood (approximately 250 μL) able to saturate 
five collection regions on the filter paper was collected by finger 
prick using a disposable lancet. Samples on filter paper were dried 
at room temperature for at least three hours and placed in indi-
vidual zip-lock bags. The bags with patient samples were sent to 
the laboratory in charge of performing analyses in up to 48 hours. 
The samples sent to the laboratory were stored under refrigera-
tion (4º C), and their bags were only opened during analysis. 
All the samples collected on filter paper were visually assessed 
as to quality and volume immediately before the analysis. Diag-
nostic sets were specifically produced to use dried samples col-
lected on filter paper and were properly registered at the National 
Health Surveillance Agency. The anti-HIV test used (Q-Preven 
HIV 1 and 2 – DBS, Prime Diagnostics) is an enzyme immu-
noassay to detect antibodies formed by the main antigenic pro-
teins of HIV-1, HIV-2 and HIV-1 subtype O. The test for syphilis 
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Table 1. Prevalence of congenital infections in 1,510 
puerperal women at Hospital Geral, Universidade de
Caxias do Sul, February 2007 to April 2008
Type of infection n  % (95% CI)
Syphilis 66  4.4 (3.4-5.5)
HIV 40 2.7 (1.9-3.6)
Toxoplasmosis 27 1.8 (1.2-2.6)
Rubella 15 1.0 (0.6-1.6)
Total 148 
Table 2. Characteristics of 1,510 puerperal  
women at Hospital Geral de Caxias do Sul, 
February 2007 to April 2008
Characteristics n* % (95%CI)
Age (years)  
 < 20 235 15.6 (13.8-17.5)
 20-35 1090 72.3 (69.9-74.5)
 > 35 183 12.1 (10.5-13.9)
Schooling  
 Illiterate 3 0.2 (0.04-0.6)
 Incomplete elementary school 673 44.6 (42.1-47.2)
 Complete elementary school 321 21.3 (19.2-23.4)
 High school 466 30.9 (28.6-33.3)
 Higher education 45 3.0 (2.2-4.0)
Job  
 Housewife 772 52.3 (49.7-54.9)
 Factory worker 457 31.0 (28.6-33.4)
 Housemaid 117 7.9 (6.6-9.4)
 Student 38 2.6 (1.8-3.5)
 Farmer 36 2.4 (1.7-3.4)
 Unemployed 30 2.0 (1.4-2.9)
 Self-employed 26 1.8 (1.2-2.6)
Family income (minimum wages) 
 < 3 983 79.1 (76.7-81.3)
 3-5 224 18.0 (15.9-20.3)
 5-10 34 2.7 (1.9-3.8)
 > 10 2 0.2 (0.02-0.6)
Prenatal care (at least six visits) 
 Yes 876 65.9 (63.9-68.5)
 No 453 34.1 (31.5-36.7)
Type of delivery  
 Vaginal 810 58.8 (56.1-61.4)
 Cesarean 568 41.2 (38.6-43.9)
Drug addiction  
 Alcohol/cocaine/crack  34 2.4 (1.7-3.4)
 No  1377 97.6 (96.2-97.9)
*Difference in values results from lost or uninformed data.
(Q-Preven Sífilis Total – DBS, Prime Diagnostics) is an enzyme im-
munoassay to detect IgM and IgG antibodies formed against the 
Treponema pallidum antigenic proteins. The tests used for toxo-
plasmosis and rubella (Q-Preven Toxoplasmose IgM – DBS and 
Q-Preven Rubéola IgM – DBS, Prime Diagnostics) are capture 
enzyme immunoassays to determine IgM against the cor-
responding etiologic agent. Analysis procedures, including 
processing of dried samples, were performed according to in-
structions provided by the manufacturer of diagnostic sets.
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Table 3. Comparison of the group of mothers with perinatal infection (Group I) and the group without infection
(Group II) in relation to perinatal results, Hospital Geral de Caxias do Sul, February/2007 to April/2008
 Group I Group II 
 (138) (1,364)  p* Or (95% CI)
 n (%) n (%)  
Abortions 23 (16.7) 223 (16.3) 0.923 1.02 (0.62-1.67)
SGA** 9 (9.0) 68 (6.7) 0.376 1.39 (0.67-2.87)
Prematurity** 23 (20.7) 164 (15.5) 0.152 1.43 (0.88-2.32)
Need of ICU 38 (27.5) 235 (17.2) 0.003 1.83 (1.23-2.72)
Neonatal death 3 (2.2) 27 (2.0) 0.752 1.10 (0.33-3.68)
Stillborns 1 (0.7) 27 (2.0) 0.507 0.36 (0.05-2.68)
Prenatal care 9 (6.5) 85 (6.2) 0.842 1.08 (0.53-2.20)
Years of schooling < 8 years 82 (59.4) 592 (43.4) < 0.001 1.91 (1.33-2.72)
Drug addiction** 12 (9.4) 22 (1.7) < 0.001 5.9 (2.9-12.3)
Syphilis and HIV 12 (34) 84 (6.1) < 0.001 8.1 (3.9-16.8)
The study was approved by the Research Ethics Commit-
tee of Universidade de Caxias do Sul.
Characteristics of the study population were presented, prev-
alence of congenital infections was calculated, and results were 
presented as percentage with respective 95% confidence intervals 
(95% CI). Later, patients were divided into two groups accord-
ing to presence or not of perinatal infection and results between 
both groups were compared using the chi-square test. Statistical 
procedures were performed using the software SPSS 15.0 (SPSS 
Inc.); p < 0.05 was considered significant for all tests.
Sample size was determined taking into consideration 
that the lowest estimated prevalence was between 0.5 and 
1.5; an approximate number of 1,500 pregnant women were 
calculated using 95% confidence level and 90% power.
RESULTS
A total of 148/1,510 puerperal women (9.8%) with positive 
results for infections were identified (Table 1). Ten pregnant 
women had more than one associated infection: four had HIV 
and syphilis, one had HIV and toxoplasmosis, two had rubella 
and syphilis, and one had toxoplasmosis and rubella. 
Table 2 shows the distribution of characteristics of the 
population in relation to some socioeconomic, pregnancy 
and delivery variables. 
From the Table, it can be seen that there was prevalence 
of patients in the age group between 20 to 35 years, and 
that 45% of the pregnant women had incomplete elemen-
tary school. Most women were unemployed, and 79% had 
family income lower than three minimum wages. There-
fore, most of the patients included in the study had low 
income and schooling level, without the required qualifica-
tion to enter the job market. In addition, 78 patients were 
involved with some type of drug.
Table 3 compared the group of patients with perina-
tal infection (Group I) and the group without infection 
(Group II) in relation to some perinatal results.
The difference between both groups was statistically 
significant as to need of ICU, maternal schooling lower 
than eight years and maternal drug addiction. 
Prevalence of infections was associated with age and 
was higher in pregnant women aged 35 years or older 
(Table 4). 
Table 4. Comparison between the groups of mothers with perinatal infection (Group I) 
and the group without infection (Group II) in relation to age
 Group I Group II
 (n = 138) (n = 1,364) p* Or (95% CI)
 n (%) n (%)  
     
< 20 years 9 (3.8) 225 (96.2) 0.006 0.39 (0.18-0.81)  
20-35 years 101 (9.3) 983 (90.7) 1    
> 35 years 28 (15.4) 154 (84.6) 0.012 1.77 (1.10-2.84)
**Difference in values results from lost or uninformed data.
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DISCUSSION
Knowledge of prevalence of infectious problems during the 
pregnancy cycle is very important in all population levels, 
especially in groups of higher risk, in which the maternal 
and child population undoubtedly has a higher number of 
complications. 
The social impact of this project concerns identifica-
tion of infectious maternal diseases that can be transmitted 
during intrauterine life and that, depending on gestational 
age, cause interruption of pregnancy, congenital malfor-
mations and intrauterine death. Research becomes more 
important as there is no reliable information on prevalence 
rates of such infections, neither on clinical outcomes re-
sulting from them.
Data are usually obtained from the international lit-
erature and are related to specific regions that cannot be 
extrapolated to studies conducted in Brazil.
This study was carried out in a population of pregnant 
women with low schooling level and income. Prevalence 
of infections under study was 9.8%, and syphilis was the 
most frequently found infection, followed by HIV, toxo-
plasmosis and rubella.
In the group of pregnant women with infection the 
number of infected women increased with age. Such in-
crease was statistically significant in women older than 35 
years. These pregnant women also had lower schooling level 
and more involvement with drugs.
Syphilis is still a major challenge to the Brazilian public 
health and brings serious consequences to the infant when 
it occurs during pregnancy. Since it is a disease that can 
be easily diagnosed and treated, untreated syphilis during 
pregnancy indicates failure in prenatal care and is, therefore, 
considered as a marker of prenatal quality. 
The total number of cases of syphilis in Brazil, from 2005 
to 2006, had an 11% increase; early latent syphilis increased 
12.4% and late latent and tertiary syphilis increased 9.9%.3
In the state of Mato Grosso do Sul, Figueiró Filho et al. 
identified a 0.8% prevalence rate of syphilis in pregnant 
women.4
Data from the Brazilian Department of Health collected 
from a representative sample of laboring women aged 15-49 
years showed a 1.9% prevalence rate in the Northeast, 1.8% in 
the North, 1.6% in the Southeast, 1.4% in the South, and 1.3% 
in the Midwest. A national study performed in 2000 showed a 
1.7% prevalence rate of syphilis in laboring women.*
This study had a three-fold higher prevalence of syphilis 
(4.4%). Such prevalence, above the national average, has fol-
lowed the increase in reports of congenital syphilis in the 
state of RS, which rose from 0.6 cases/1,000 live births in 
1998 to 1.4 cases/1,000 live births in 2006. The highest rates 
found in RS may not be a reflection of a more unfavorable 
reality than that of other states, but of intense efforts to de-
tect and report the disease since under diagnosis and under-
reporting of syphilis are still high. 
The World Health Organization had already reported 
that at least 30-40 million adults should be infected by the 
human immunodeficiency virus (HIV) by 2000; of these, 
90% would be from developing countries and half would 
be women.5
Although the result of the protocol ACTG 076 (AIDS 
Clinical Trials Groups 076), in which zidovudine (AZT) 
is administered to pregnant women and to their children 
gave new meaning to our ability of fighting the epidemics 
of AIDS in children, vertical transmission of HIV is still 
high worldwide.6
In Brazil the proportion of HIV-positive women has 
increased quickly, especially in the low-income popula-
tion. The age group with the highest number of HIV/AIDS 
cases in women reported by the Brazilian Department of 
Health is between 20 and 39 years, which coincide with re-
productive age. As the number of infected women grows, 
the threat of an increase in number of children exposed 
to the virus becomes more real. Today 90% of cases of 
HIV-infected children in Brazil are due to maternal-child 
transmission. For that reason, the health policy used by the 
Brazilian Ministry of Health emphasizes the need of early 
identification of the population vulnerable to HIV trans-
mission during the pregnancy cycle.7
The study identified a 2.7% prevalence rate of HIV 
infection. A study conducted in Porto Alegre, RS, Brazil, 
showed that HIV seroprevalence ranged between 0 and 
8%, depending on city area.8 Areas with lower income, 
lower schooling level and higher fertility rate were those 
with the highest prevalence.7
Another study performed in 27 municipalities in South-
ern Brazil found 0.5% HIV-positive pregnant women in a 
sample of 8,002 patients. The only variable associated with 
seropositivity for HIV was schooling level, nearly three times 
lower in women with eight or more years of formal educa-
tion than in those that had three or less years of education. 
Pregnant women that were younger, single, unemployed and 
had lower schooling level comprised the higher exposure 
group.9
In the current study, low schooling and use of drugs had 
a statistically significant relationship with a higher number 
of cases of syphilis and HIV, showing the strong association 
between such diseases and number of years of study and in-
crease in drug use among pregnant women.
Toxoplasmosis is an infection with considerable public 
impact. Its prevention is not simple since its occurrence is 
influenced by the host’s genetics, immunity and behavior. 
The high prevalence of anti-Toxoplasma gondii antibod-
ies is attributed to some geographical discrepancies related 
to climactic conditions, life and eating habits, hygiene and 
* Brazil. Ministry of Health. Secretariat of Health Surveillance. 
STD/Aids National Program. Estudo Sentinela. Parturiente Corte 
Nacional – October 2000.
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cultural differences. The main risk factors for toxoplasmosis 
during pregnancy are parity, older age, race, immunodefi-
ciency, eating habits, contact with cats and soil.10
In addition, developed countries have lower seroposi-
tivity rates than developing countries. In the United States 
approximately 20-25% of women of reproductive age had 
positive serologic test for previous infection by Toxoplasma 
gondii, which shows that 75% of pregnant women are sus-
ceptible to this disease. 
In Italy a study performed in 3,426 pregnant women 
showed seroprevalence of 21.5% and acute infection of 
1.2% in samples treated by the ELISA method.11 Similar se-
roprevalence rates were described by other authors.12,13
In this study the rate of previous infection by Toxoplas-
ma gondii was 24.7%, similar to that of developed countries, 
and acute infection rate during pregnancy was 1.8%. Slightly 
higher rates were described in European prospective studies, 
which showed an infection incidence of 2-8%.12,14-17
However, when rates of acute infection and seropreva-
lence were compared with other Brazilian studies, acute 
infection during pregnancy is higher and seroprevalence is 
much lower than in other studies. Such differences are prob-
ably related to cultural aspects, different life and develop-
ment habits. A study conducted in the state of Mato Grosso 
do Sul showed a 0.4% frequency of this disease.4 Another 
study performed in the Brazilian Midwest region showed a 
0.42% frequency for acute infection by Toxoplasma gondii in 
the population of pregnant women, 92% of whom had been 
previously exposed to the infection.18
A study conducted in Recife, state of Pernambuco, Brazil, 
showed that 74.7% were seropositive, 22.5% were suscepti-
ble and 2.8% had active infection. There was no relationship 
between infection and age, morbidity and gestational age. 
However, there was a significant association with schooling 
and higher susceptibility in pregnant women with eight or 
more years of education.19
In Cali, Colombia, the seroprevalence rate was 45.8%, and 
acute infection was 2.8%. Seroprevalence significantly increased 
with age (39% - 14 to 19 years vs. 55.3% - 30 to 39 years). In-
creased seroprevalence in relation to age was more significant in 
lower socioeconomic classes. There was also lower seroprevalence 
in higher socioeconomic levels (low: 49% vs. high: 29%).20
In the area of infectious and contagious diseases, the epide-
miological importance of rubella is represented by occurrence 
of congenital rubella syndrome (CRS), which affects the fetus 
or newborn whose mothers were infected during pregnancy.21 
During the worldwide epidemics of rubella in 1962-
1965, there were 12.5 million cases in the United States, 
resulting in 2,000 cases of encephalitis, 11,250 fetal deaths, 
2,100 neonatal deaths and 20,000 newborns with CRS, a se-
ries of defects that include deafness, blindness and cardiac 
malformations, generating an economic impact estimated 
in US$ 1.5 billion in the USA.22
In 1997 the Pan-American Health Organization recom-
mended strategies to control the disease. Rubella vaccination 
was licensed in 1969; since then, the incidence of rubella and 
CRS has been reduced substantially.23 
In 2005 the Center for Disease Control and Prevention 
(CDC) announced the elimination of endemic rubella and 
CRS in the USA.24 Such occurrence was probably due to a 
large vaccination coverage (in more than 95% of school-age 
children) and high immunity rate in the population (91%). 
In Brazil the vaccine against rubella was gradually imple-
mented from 1992 (São Paulo) and 2000, when all states had 
the measles-mumps-rubella (MMR) vaccination imple-
mented in all health units. Data from the Brazilian Depart-
ment of Health reported that there were 4,408 cases of ru-
bella in the country from 2002 to 2007, which corresponds 
to a 95% decrease when compared with the incidence in 
1997. However, there are still rubella outbreaks.25 In 2007 
the Brazilian Department of Health confirmed rubella out-
breaks in 20 states and in 577 towns, representing a total of 
8,683 cases. In the state of Rio Grande do Sul, Brazil, the 
number of cases was 2,852, and there were two confirmed 
cases of CRS. 
In this study the prevalence of rubella in pregnancy was 
1% (15 cases), a similar index to that found in Londrina, 
state of Paraná, Brazil (1.2%).26
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